|4Feb 21, 10:02 AM ET

COMMISSIONG GERALD 4

4 · AMARANTUS BIOSCIENCE, INC. · Filed Feb 21, 2013

Insider Transaction Report

Form 4
Period: 2013-02-21
COMMISSIONG GERALD
DirectorCEO10% Owner
Transactions
  • Purchase

    Common Stock

    2013-01-11$0.07/sh+10,000$7427,502,300 total
  • Purchase

    Common Stock

    2013-01-11$0.07/sh+15,000$1,1157,517,300 total
  • Purchase

    Common Stock

    2013-01-11$0.07/sh+15,000$1,1157,517,300 total
  • Purchase

    Common Stock

    2013-01-14$0.09/sh+15,000$1,3657,542,300 total
  • Purchase

    Common Stock

    2013-02-05$0.08/sh+47,900$4,0197,590,200 total
  • Purchase

    Common Stock

    2013-02-05$0.08/sh+2,100$1767,592,300 total
  • Purchase

    Common Stock

    2013-02-21$0.07/sh+50,000$3,6257,642,300 total
  • Award

    Common Stock Options

    2011-05-04$0.03/sh+269,329$7,272269,329 total
    Exercise: $0.03CommonStock (269,329 underlying)
  • Award

    5% Convertible Preferred Stock

    2012-07-15+471,25023,531,829 total
    Exercise: $1.50Common Stock (23,562,500 underlying)
  • Award

    5% Convertible Preferred Stock

    2012-11-04+500,00048,531,829 total
    Exercise: $1.50CommonStock (25,000,000 underlying)
Footnotes (3)
  • [F1]No specific date set.
  • [F2]Set based upon current price, actual price will be determined on the date of conversion.
  • [F3]N/A

Documents

1 file
  • 4
    v335855_4.xmlPrimary

    OWNERSHIP DOCUMENT